Jamison Private Wealth Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $602 Billion
- Q2 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 135 shares of REGN stock, worth $143,216. This represents 0.02% of its overall portfolio holdings.
Number of Shares
135
Previous 135
-0.0%
Holding current value
$143,216
Previous $130 Million
9.2%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,440Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.47 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$9.09 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.2 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.14 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.94 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $114B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...